Flamel's finances flounder after string of setbacks
Troubled firm Flamel reported a sharp decrease in total third quarter revenues - $3.1 million (€2.6 million), compared to $13.3 million this time last year - resulting in a net loss $11.9 million.
Troubled firm Flamel reported a sharp decrease in total third quarter revenues - $3.1 million (€2.6 million), compared to $13.3 million this time last year - resulting in a net loss $11.9 million.
The Parenteral Drug Association (PDA) recently held a conference in Munich to fuel the further development of the growing pre-fillable syringe market.
Lonza and Solvias have confirmed their long-term collaboration in the development and transfer of asymmetric reactions to an industrial scale.
Millipore has launched a new reverse osmosis (type III) water purification system, designed to meet the needs of laboratories that only require up to 30 L/day of purified tap water.
US consumers could have saved $20 billion (€16.6 billion) in 2004 and even more could be saved in future years by using more generic drugs, according to a new report by Express Scripts.